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INTRODUCTION   
The World Health Organization (WHO) addressed drug 
utilization as the marketing, distribution, prescription and 
use of drugs in a society, considering its consequences, 
either medical, social, and economic.
1 
Studies on the 
process of drug utilization focus on the factors related to 
the prescribing, dispensing, administering, and taking of 
medication, and its associated events, covering the medical 
and non-medical determinants of drug utilization, the 
effects of drug utilization, as well as studies of how drug 
utilization relates to the effects of drug use, beneficial or 
adverse.
2, 3, 4 
The therapeutic practice is expected to be 
primarily based on evidence provided by pre marketing 
clinical trials, but complementary data from post 
marketing period are needed to provide an adequate basis 
for improving drug therapy.
5 
The rapidly expanding field of psychopharmacology is 
challenging the traditional concepts of psychiatric 
treatment and research, and is constantly seeking new and 
improved drugs to treat psychiatric disorders. In this way, 
psychiatrists are continuously exposed to newly introduced 
drugs that are claimed to be safe and more efficacious. 
Although psychotropic medications have had a remarkable 
impact on psychiatric practice that legitimately can be 
called revolutionary, their utilization and consequences on 
real life effectiveness and safety in actual clinical practice 
need continuous study.
6
 
On this background, the study was conducted to evaluate 
the prescribing pattern of antipsychotic drugs in psychotic 
illness in a tertiary care teaching hospital in West Bengal. 
MATERIALS AND METHODS 
 ETHICAL CONSIDERATIONS  
The study protocol, along with the informed consent form 
(in Bengali, Hindi & English) was submitted to the 
Institutional Ethics Committee, Burdwan Medical College, 
Burdwan, for approval. Subject recruitment commenced 
only after such approval was obtained in writing.  
Informed written consent was taken from the legally 
acceptable representative of each participant. Illiterate 
individuals will give their fingerprint (left thumb 
impression) instead of signature in the presence of an 
appropriate witness. 
 STUDY SETTING 
The study was conducted in the Psychiatry out-patient 
department (OPD) Burdwan Medical College & Hospital, 
Kolkata (B.M.C & H).  
Data compilation and Statistical analysis: In Department 
of Pharmacology, Burdwan Medical College & Hospital, 
Kolkata (B.M.C & H). 
STUDY DURATION- The duration of study was three 
months (October 2012 to January 2013). 
STUDY DESIGN:  
The current study was designed as a Cross sectional and 
unicentric drug utilization study.  
SUBJECT SELECTION CRITERIA  
The subjects who had willingly participated were enrolled 
on the basis of inclusion and exclusion criteria. All the 
patients using antipsychotic drugs, between 18-60 years of 
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age, irrespective of sex, were included in the study. 
However, patients who were pregnant, lactating, unable to 
comply due to mental retardation, any systemic illness 
,unconsciousness or drug addiction were excluded from 
the study.  
STUDY POPULATION: 
The present study was conducted on 510 patients who 
visited the Psychiatry outdoor unit during October 2012 to 
January 2013.  
PARAMETERS FOR EVALUATION:  
The parameters included gender distribution, age of the 
patients, type of illness, types of antipsychotic medication 
prescribed, prescribed in generic form, average number of 
drugs per prescription, percentage of the drugs prescribed 
from NLEM 2011(National List of Essential Medicines of 
India),and percentage of injectable drugs prescribed per 
day.  
STUDY METHODOLOGY:  
This cross-sectional, unicentric study was conducted in the 
Psychiatry outpatient department (OPD) of an urban, 
tertiary care, Medical College & Hospital in west Bengal 
during October 2012 to January 2013. Prescriptions were 
collected from patients attending the psychiatry OPD 
suffering from any psychotic illness. The prescription 
patterns of antipsychotic agents were analyzed. No follow 
up of prescription was done. 
RESULT AND ANALYSIS  
In a fourth months period from October 2012 to January 
2013, a total of 510 patients were included in the study and 
their prescriptions containing at least one antipsychotic 
were analyzed only once time- no follow up visit was 
done. The demographic profile has been described in 
TABLE 1,2and FIGURE 1, 2 and 3. 
 
Table 1: Shows demographic parameters 
 
Table 2: Who recommended prescribing indicators (N = 510) 
 
 
 
 
 
 
 
PATIENT CHARACTERISTICS NUMBER OF PRESCRIPTION (N=510) PERCENTAGE (%) 
          AGE IN YEARS 
18-30 265 51.9 
31-40 90 17.6 
41-50 70 13.7 
51-60 60 11.7 
61-70 25 4.9 
                            SEX 
MALE 279 54.7 
FEMALE 231 45.29 
MALE:FEMALE RATIO  1.20:1 
DIAGNOSIS 
Organic mental disorder (F 0-9) 15 2.94 
Mental disorder due to substance abuse (F 10-19) 25 4.9 
Schizophrenia delusional disorder (F 20-29) 235 46 
Mood disorder (F 30-39) 155 30.39 
Neurotic & somatoform disorder(40-49) 35 6.86 
F 50-59 0 0 
Disorder of adult personality and behavior (F 60-
69) 
5 0.9 
Mental disorder (F 70-79) 20 3.9 
No diagnosis  20 3.9 
PRESCRIBING INDICATORS: Average number of drugs /prescription        1.07 
Average number of antipsychotic drug/prescription 1.07  
 Percentage of the drugs prescribed by generic name  92.66%  
 Percentage of the drugs prescribed from NLEM 2011  89.89%  
Percentage of the drugs supplied from hospital pharmacy  90.83%  
Percentage of injectable drugs prescribed per day  4.59%  
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Figure 1: Shows Age-Wise Distribution of Illness 
 
Figure 2: Shows Sex-Wise Distribution Of Illness
 
 
Figure 3: Shows Distribution of Illness 
The distribution of drugs according to drug category-either atypical or typical antipsychotic are tabulated in table no 3. 
 
Table 3: Distribution of drugs (total no of prescribed drugs N=545) 
 
 
 
 
 
 
From the previous table it is seen that olanzapine were prescribed in higher number. The doses (mg/day) of olanzapine in 
various psychotic illness are tabulated in table no 4. 
Age wise distribution  
18-30
31-40
41-50
51-60
61-70
55% 
45% 
sex wise distribution 
male female
15 25 
235 
155 
35 0 
5 20 20 
0
50
100
150
200
250
Type of drug Name No Percentage 
Atypical antipsychotic Olanzapine 420 77.06 
Risperidone 45 8.26 
Quetiapine 10 1.83 
Typical antipsychotic Haloperidol 60 11 
Trifluperidol 10 1.83 
Anticholinergic Trihexyphenidyl 60 11 
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Figure 4: Doses ((Mg/Day) of Olanzapine in Various Psychotic Illnesses 
The antipsychotic drugs were either prescribed in 
combination or singly in each prescription. But it was seen 
that majority prescription contained single antipsychotic 
drug, presented in table no 3 (total prescription =510) and 
figure no 4. 
Table 4: Distribution of Prescription (Total No of 
Prescription, N=510) 
 
 
Figure 5: Shows Prescription Pattern either Mono-
Therapy or Poly-Therapy 
During analysis of prescription it was seen that maximum 
drugs were supplied from the hospital in free of cost where 
less percentage of drugs were purchases from outsides, 
represented in figure 6. 
 
 
Figure 6: Sources of Drugs 
DISCUSSION   
Most of the published guidelines for the use of 
antipsychotic favor the use of atypical ones, 
7
 the majority 
of the patients (87.15%)   [475/545] in this study, were 
receiving the atypical antipsychotic medications 
particularly olanzapine and risperidone. Less than 13% 
[70/545] patients received the typical antipsychotics. This 
is in accordance with the general findings that clinical 
efficacy and safety of these conventional antipsychotics 
were shown to be less than that of atypical new generation 
antipsychotic medications. 
8, 9
 
Schizophrenia was more common in males. Disorder was 
more common in the age group of 18-30 years. 
In the governmental sector, the majority of patients in west 
Bengal who are receiving typical antipsychotic 
medications are usually denied access to the newer 
atypical drugs until they have failed to respond to or 
tolerate conventional treatments. This pattern of usage is 
not due to unavailability atypical antipsychotic, rather, it 
might be due to the cost difference between the typical and 
atypical antipsychotic. 
0 1 2 3 4 5 6 7 8 9
F 0-9
F 10-19
F 20-29
F 30-39
F 40-49
F 50-59
F 60-69
F 70-79
monotherapy vs polytherapy 
monotherapy
polytherapy
Type of prescription Number of 
prescription 
Percentage 
(%) 
Monotherapy of 
antipsychotic 
480 94% 
Polytherapy of 
antipsychotic 
30 6% 
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Among those patients receiving the typical antipsychotic 
medications, (22/124) were receiving two - drug 
combination antipsychotics. Similar patterns of 
polypharmacy have been noted in other countries.  
In Australia, one study shows 13 percent of all outpatients 
received more than one antipsychotic medication,
 10 
in 
another study, 47 percent of patients received prescriptions 
for two antipsychotic medications, and 8 percent received 
prescriptions for three medications.
11 
In our study group, approximately 6% of the patients were 
receiving multiple antipsychotic medications.  
Important findings were drug prescribed in generic form in 
higher percentage (92.66 %) and majority of drugs 
(89.89%) prescribed from NLEM 2011.The reason may be 
due to free supply of medicine in government hospital. 
Finally, it was seen that, prescription containing typical 
antipsychotic drugs also contained anticholinergic agent 
due to protective effect against extrapyramidal side effects 
of the neuroleptic drugs. Trihexyphenidyl was the only 
anticholinergic drug prescribed by psychiatrists in 
Burdwan Medical College & Hospital. This 
underutilization of the protective anticholinergic 
medications to be co-prescribed with typical antipychotics 
increases the risk of extrapyramidal side effects and other 
toxicities. 
CONCLUSION  
To conclude, our study shows, patients suffering from 
psychotic illness mainly advised monotherapy of 
antipsychotic drugs, mainly atypical antipsychotic drugs, 
and olanzapine is the most prescribed antipsychotic drugs. 
Trihexyphenidyl is the only antichoninergic drug co-
prescribed with typical antipsychotic drugs to avoid 
extrapyramidal side effects. 
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